about
Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.Trends in methicillin-resistant Staphylococcus aureus anovaginal colonization in pregnant women in 2005 versus 2009Canadian paediatricians' approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic networkSpontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.Predictors of Staphylococcus aureus Rectovaginal Colonization in Pregnant Women and Risk for Maternal and Neonatal Infections.Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers.A global survey of adverse event following immunization surveillance systems for pregnant women and their infantsAdverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.Vasculitis as an adverse event following immunization - Systematic literature review.Kawasaki disease and immunisation: A systematic review.Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics Network.Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.Fatal pneumococcal meningitis in a 7-year-old girl with interleukin-1 receptor activated kinase deficiency (IRAK-4) despite prophylactic antibiotic and IgG responses to Streptococcus pneumoniae vaccines.Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program.Guillain-BarrÉ Syndrome After Immunization in Canadian Children (1996-2012).Adverse event following immunization surveillance systems for pregnant women.Development of an Evidence-Based Antimicrobial Stewardship Smartphone App in a Tertiary Academic Pediatric and Women’s Health Centre in Canada.Invasive Haemophilus influenzae Type b (Hib) Infections in Children with Cancer in the Era of Infant Hib Immunization Programs (1991-2014): A Report from the Canadian Immunization Monitoring Program Active.Effect of package insert language on health-care providers' perceptions of influenza vaccination safety during pregnancy.Risk of seizures after immunization in children with epilepsy: a risk interval analysis.Immunizing Patients with Adverse Events Following Immunization in the Canadian Special Immunization Clinic Network (2015–2017)Pertussis immunization in paediatric healthcare workers: knowledge, attitudes, beliefs, and behaviourDetection of mutations in antigenic regions of rotavirus viral proteins 4 and 7 in a child with chronic shedding of rotavirus vaccine-type strainFrom mother to baby: antenatal exposure to monoclonal antibody biologicsHealth outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort studyCompleteness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic reviewRate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance In Quebec, CanadaAcute encephalopathy associated with influenza infection: Case report and review of the literatureLive vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018Risk of Recurrence of Adverse Events Following Immunization: A Systematic Review
P50
Q31119651-C7877FB9-A564-428F-B8EF-9C7E9BA1FD06Q31143319-2210F6E6-FF95-4525-844D-E458CD4954BEQ34190452-A37EB1C7-DCB0-415D-8799-2C7102BDDC0BQ34238443-719654ED-CBFB-4DA8-B6C4-E4FA130D5787Q35782657-43D904D9-173B-4D4E-A88C-5C9FBF9DA2B9Q36851151-F776C3D1-17F0-4D9F-9CD9-9799CB901D03Q37130759-2924FDF1-AC15-4058-9494-012935544479Q37197142-B3C77D46-8628-4C18-8759-7D1DFDA1CEE7Q38356351-837E9722-54A3-4AAB-AB12-C44BBBA8CD97Q38591612-1B1F92BE-CA10-48C9-9A7B-B173855DB890Q38750758-202C6991-EDFB-4172-8E46-303600452C8EQ39391825-66E244C6-0CC6-4249-A256-8C66AEDCC681Q39683218-D7EE2937-BA8C-493A-871A-2F5F26286C8BQ40215728-3CE7FCD6-EDD1-4CB9-8779-E18D6308A2D4Q40232457-30D3C4B9-C7A1-4CD5-AACD-C370E2B78B4CQ40271669-35317772-E696-455E-A6C0-3691C5E2511FQ40995038-133B660A-C541-403C-A9A1-2906718D17E6Q46663778-17E74C3A-2CC6-4784-A057-2E97D6A54388Q47239124-458F8E9B-0D44-4B61-BB15-16942C54A9CCQ50098973-82C2D20C-387C-449E-861A-4982AC882E1AQ53751529-138BC81A-9FB4-42CA-BD5B-613AE3AB50BAQ54237548-919BF1BD-C84A-41C8-AC40-A3816B19F4B8Q58423298-C18E958F-A2F7-4E13-8357-33969FE1D403Q82427658-73DCFEB8-0964-4FC8-9A4E-43CF515473CDQ84362125-C74BE519-D66F-4168-8F97-D21A9E175090Q90662682-8A1A8DF3-8EE8-4500-BCD2-EB0822CBA031Q91774677-CFDD59E4-BABA-461F-AF74-CA0946FBC5BBQ91982564-0331C406-E31C-4B00-BD00-525366E76101Q92437946-DD1307B7-4485-4AB7-899E-BF6E33E020DEQ93165300-48857BEF-65F0-41CC-B60D-238A1FF58E8EQ93191734-F5763FED-5553-40F8-9FCD-11D95979EC6FQ95724865-37D2AA47-6352-44C8-BE7A-BB7C7B3FA57A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Karina A Top
@ast
Karina A Top
@en
Karina A Top
@es
Karina A Top
@nl
type
label
Karina A Top
@ast
Karina A Top
@en
Karina A Top
@es
Karina A Top
@nl
prefLabel
Karina A Top
@ast
Karina A Top
@en
Karina A Top
@es
Karina A Top
@nl
P106
P1153
36088295300
P21
P31
P496
0000-0002-9981-368X